You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page

No matches

33 search results for: asthma

Airway Remodeling in Type 2 <b>Asthma</b> is Driven by IL-4 and IL-13

expert video

Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13

24 min

Pulmonology

Dr. Reynold Panettieri discusses how IL-4 and IL-13 drive airway remodeling in type 2 asthma.

FeNO: A Biomarker of Type 2 Inflammation in Pediatric <b>Asthma</b> Patients

Infographic

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients

5 min

Pulmonology

Learn about the role of FeNO as a noninvasive test to identify type 2 inflammation in pediatric patients with asthma

Adult <b>Asthma</b> Interactive Patient Cases

interactivity

Adult Asthma Interactive Patient Cases

15 min

Pulmonology

Explore 3 hypothetical patient cases using guideline-based checklists for assessment and diagnosis of type 2 inflammation in adult asthma

Pediatric <b>Asthma</b> Patient Case Tool: Ash

interactivity

Pediatric Asthma Patient Case Tool: Ash

5 min

Pulmonology

Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients

The Cycle of Inflammation in Adult <b>Asthma</b>

interactivity

The Cycle of Inflammation in Adult Asthma

5 min

Pulmonology

Explore the role of chronic type 2 inflammation in the cycle of exacerbations and worsening lung function in asthma patients

Expert Insights: Importance of Lung Function Assessment in Pediatric <b>Asthma</b> Patients

expert video

Expert Insights: Importance of Lung Function Assessment in Pediatric Asthma Patients

2 min

Pulmonology

Dr. Michael Blaiss describes the importance of lung function assessment in pediatric asthma management

expert video

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission

8 min

Pulmonology

Watch Prof G. Walter Canonica discuss the need to move beyond disease control to clinical remission in asthma and CRSwNP.

Importance of Lung Function Assessment in Adult <b>Asthma</b> Patients

videoanimation

Importance of Lung Function Assessment in Adult Asthma Patients

3 min

Pulmonology

Review the burden associated with lung function decline in adult patients with severe asthma, and the value of clinical lung function assessments.

expert video

The Risks of Associated Systemic and Atopic Comorbidities with AD

5 min

Dermatology

Dr. Paller explores the multifaceted impact of AD, highlighting its association with various comorbidities such as food allergies, asthma, allergic rhinitis, and mental health disorders.

Why Is It Important to Assess Lung Function in Pediatric Severe <b>Asthma</b> Patients?

expert video

Why Is It Important to Assess Lung Function in Pediatric Severe Asthma Patients?

18 min

Pulmonology

Prof. Monika Gappa presents the importance in assessment of lung function in pediatric patients alongside the associated patient burden.

interactivity

Type 2 Inflammation Digital Assessment Tool

4 min

Pulmonology

Learn how to assess patients for the presence of uncontrolled asthma driven by underlying type 2 inflammation.

A Triad of Interacting Mechanisms Driving the Pathophysiology of AD, <b>Asthma</b>, CRSwNP, and EoE

Infographic

A Triad of Interacting Mechanisms Driving the Pathophysiology of AD, Asthma, CRSwNP, and EoE

5 min

Type 2 Inflammation

Discover how barrier dysfunction, neuroimmune dysregulation, and type 2 inflammation contribute to the pathophysiology of various diseases

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: FranceChange country/region